Episode Details
Back to Episodes
234: Biogen's new CEO, how the midterms affect science, & a biotech bankruptcy
Published 3 years, 11 months ago
Description
STAT Washington correspondent Sarah Owermohle joins us to explain how this week's midterm elections will affect health and medicine, and what the politicization of the pandemic means for the future of science in the U.S. We also discuss the incoming CEOs of Biogen and Seagen, plus a pair of biotech collapses.